On pre-treatment biopsy, PD-L1 expression was noted on 0% of tumor cells and 10% of immune cells, with a CPS of 5, above the threshold for positivity of ≥ 1, but below the ≥ 10 threshold. The gene discussed is CD274; the disease is neoplasm.